Enoxaparin as Treatment for Vulvodynia

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators hypothesize that injections of Low molecular weight heparin (LMWH) [enoxaparin] will reduce pain in women with vulvodynia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Western Galilee Hospital-Nahariya
• Treatments: Enoxaparin

Criteria

Inclusion Criteria:

• women with vulvodynia

Exclusion Criteria:

• women without vulvodynia